Non-hormonal treatment of hot flushes in breast cancer survivors: gabapentin vs. vitamin E
Authors:
- N. BigliaNBN. Biglia
- P. SgandurraPSP. Sgandurra
- E. PeanoEPE. Peano
- D. MarencoDMD. Marenco
- G. MoggioGMG. Moggio
- V. BounousVBV. Bounous
- N. Tomasi ContNCN. Tomasi Cont
- R. PonzoneR. Ponzone
- P. SismondiPSP. Sismondi
- 1 January 2009
- journal article
- research article
- Published by Taylor & Francis in Climacteric
- Vol. 12 (4) , 310-318
Abstract
To assess the efficacy and the tolerability of gabapentin 900 mg/day compared to vitamin E for the control of vasomotor symptoms in 115 women with breast cancer. The secondary objective was to evaluate the effect of the treatments on the quality of sleep and other aspects of the quality of life. A hot flush diary was completed daily; sleep quality and other menopausal symptoms were assessed with the Pittsburgh Sleep Quality Index (PSQI), the Menopause Rating Scale (MRS) and the SF-36 Health Survey. The prescribed treatment with gabapentin was never started by 28.3% of the patients and was interrupted by 28% for side-effects (dizziness and somnolence). Among the women allocated to vitamin E, 16.36% never started therapy and 34.78% dropped out because of inefficacy. Hot flush frequency and score decreased by 57.05% and 66.87%, respectively (p < 0.05) in the gabapentin group. The effect of vitamin E was fairly small: hot flush frequency and score were reduced by 10.02% and 7.28%, respectively (p > 0.05). Gabapentin was also particularly effective in improving the quality of sleep (PSQI score reduction: 21.33%, p < 0.05). Gabapentin appears to be effective for the treatment of hot flushes with a favorable effect on quality of sleep. Vitamin E has only marginal effect on vasomotor symptoms.Keywords
This publication has 13 references indexed in Scilit:
- Increased Risk of Recurrence After Hormone Replacement Therapy in Breast Cancer SurvivorsJNCI: Journal of the National Cancer Institute, 2008
- Gabapentin for the treatment of menopausal hot flashesMenopause, 2008
- Mirtazapine for the Treatment of Hot Flushes in Breast Cancer Survivors: A Prospective Pilot TrialThe Breast Journal, 2007
- Menopausal symptoms in women treated for breast cancer: the prevalence and severity of symptoms and their perceived effects on quality of lifeClimacteric, 2006
- Gabapentin for hot flashes in 420 women with breast cancer: a randomised double-blind placebo-controlled trialThe Lancet, 2005
- Treatment of menopause-associated vasomotor symptoms: position statement of The North American Menopause Society: RetractedMenopause, 2004
- Gabapentin's effects on hot flashes in postmenopausal women: a randomized controlled trialObstetrics & Gynecology, 2003
- Venlafaxine in management of hot flashes in survivors of breast cancer: a randomised controlled trialThe Lancet, 2000
- Gabapentin’s effects on hot flashes and hypothermiaNeurology, 2000
- Prospective evaluation of vitamin E for hot flashes in breast cancer survivors.Journal of Clinical Oncology, 1998